Ch 31: Communicating Results to the patient Need to communicate results to patient How to communicate results to TB patient
Ch 29: Stigma, Discrimination and Gender sensitivity Stigma and Discrimination towards TB Patient Effects of Stigma on TB Patients Gender Aspects of TB Addressing Gender Inequalities
Ch 28: TB Treatment Adherence TB Treatment Adherence Importance of Treatment adherence Recording and Monitoring Adherence Digital Adherence Monitoring Technologies Recording manual doses in Ni-kshay Recording missed doses in Ni-kshay
Ch 27: Comorbidity screening and testing TB Co-morbidities & Special Situations HIV in TB Patients Diabetes among people with TB TB in Pregnant and Lactating Women COVID-19 in TB patients
Ch 26: Public Health Actions for TB Public Health Actions Contact Tracing and Investigation Direct Benefit Transfer [DBT] under NTEP Various Direct Benefit Transfer Schemes Linkages to Social Welfare Schemes
Ch 25: TB Preventive Therapy TB Preventive Therapy Eligibility for TPT Testing for TB Infection Regimen for TPT
Ch 24: TB Treatment initiation and Follow-up TB Treatment Initiation Follow-up of TB patient TB Treatment Outcome Adverse Drug Reactions [ADRs] Long Term Post-treatment follow up of TB patients Universal Drug Susceptibility Testing [UDST] Screening and diagnosis for DRTB
Ch 23: General Concepts in TB Treatment for LT First line anti TB drugs TB Drug Regimen Treatment Phases FDCs used in NTEP
Ch 22: Biomedical Waste Management at DMC Color Coding and Type of Container in Biomedical Waste Management Disposing Off Contaminated Material Safely in Microscopy Centre Laboratory Setting Preparation of TB Lab Disinfectants Roles of various stakeholders in IPC
